Evidence map›Paper›PMID 37726670›Full record

ArticleMolecular medicine (Cambridge, Mass.)2023

Correction: Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity.

Xiaoxia Xiao, Huiling Hu, Yadi Zhong, Yingjian Chen, Kaijia Tang, Zhisen Pan, Jiawen Huang, Xiaoying Yang, Qi Wang, Yong Gao

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xiaoxia Xiao *Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Huiling Hu *Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, China.
Yadi Zhong *Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Yingjian ChenScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Kaijia TangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zhisen PanFirst Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Jiawen HuangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Xiaoying YangJiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. yxyxiaoliqq@163.com.
Qi WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. wangqi@gzucm.edu.cn.
Yong GaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. gaoyong@gzucm.edu.cn.ORCID https://orcid.org/0000-0002-7795-3649
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNSun Yat-sen University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37726670
PMCPMC10507847
OpenAlexW4386845426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.